• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过前体药物异环磷酰胺和5-氟胞嘧啶的局部激活对小鼠乳腺肿瘤进行联合化疗。

Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine.

作者信息

Kammertoens T, Gelbmann W, Karle P, Alton K, Saller R, Salmons B, Günzburg W H, Uckert W

机构信息

Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.

出版信息

Cancer Gene Ther. 2000 Apr;7(4):629-36. doi: 10.1038/sj.cgt.7700139.

DOI:10.1038/sj.cgt.7700139
PMID:10811482
Abstract

The success of chemotherapeutic intervention is limited because the necessary high local drug doses cannot be achieved without systemic toxicity. Application of suicide genes (SGs) and direct conversion of prodrugs (PDs) to toxic metabolites in situ by SGs may enhance the efficacy of chemotherapy. To evaluate this strategy in two murine breast cancer models, TS/A and GR, we injected cellulose sulfate capsules harboring cat kidney cells expressing the SGs cytosine deaminase and cytochrome P450 2B1 (CYP2B1) intratumorally. The PDs 5-fluorocytosine and ifosfamide were administered in 3-day intervals. The effect of in situ chemotherapy with each PD alone and the combination was analyzed over a period of 100 days. The results reveal that for TS/A tumors, the antitumoral effect mediated by CYP2B1 is more efficient than that of cytosine deaminase, whereas for GR tumors, both systems worked equally well. Furthermore, we find additive toxicity using both SG/PD systems for both TS/A and GR tumors.

摘要

化疗干预的成功受到限制,因为在不产生全身毒性的情况下无法达到所需的高局部药物剂量。应用自杀基因(SGs)以及通过SGs将前体药物(PDs)原位直接转化为有毒代谢物可能会提高化疗效果。为了在两种小鼠乳腺癌模型TS/A和GR中评估该策略,我们将携带表达SGs胞嘧啶脱氨酶和细胞色素P450 2B1(CYP2B1)的猫肾细胞的硫酸纤维素胶囊瘤内注射。每隔3天给予PDs 5-氟胞嘧啶和异环磷酰胺。在100天的时间内分析了单独使用每种PD以及联合使用时原位化疗的效果。结果显示,对于TS/A肿瘤,CYP2B1介导的抗肿瘤作用比胞嘧啶脱氨酶更有效,而对于GR肿瘤,两种系统的效果相同。此外,我们发现对于TS/A和GR肿瘤,使用两种SG/PD系统均具有累加毒性。

相似文献

1
Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine.通过前体药物异环磷酰胺和5-氟胞嘧啶的局部激活对小鼠乳腺肿瘤进行联合化疗。
Cancer Gene Ther. 2000 Apr;7(4):629-36. doi: 10.1038/sj.cgt.7700139.
2
Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450.通过瘤内注射经基因工程改造以产生CYP2B1(一种异环磷酰胺激活细胞色素P450)的封装细胞进行靶向化疗。
Gene Ther. 1998 Aug;5(8):1070-8. doi: 10.1038/sj.gt.3300671.
3
In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.通过腺病毒介导的双功能酵母胞嘧啶脱氨酶/尿嘧啶磷酸核糖基转移酶融合基因转移进行体内癌症基因治疗。
Cancer Res. 2000 Jul 15;60(14):3813-22.
4
Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.细胞色素P450还原酶依赖性对细胞色素P450 2B1活性的抑制:对基因导向酶前药疗法的影响。
Biochem Pharmacol. 2006 Sep 28;72(7):893-901. doi: 10.1016/j.bcp.2006.06.012. Epub 2006 Aug 2.
5
Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.胞嘧啶脱氨酶/5-氟胞嘧啶基因疗法产生的瘤内5-氟尿嘧啶对实验性人类胶质母细胞瘤有效。
Cancer Res. 2002 Feb 1;62(3):773-80.
6
Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide.细胞色素P450激活异环磷酰胺引起的是坏死性细胞死亡,而非凋亡性细胞死亡。
Cancer Gene Ther. 2001 Mar;8(3):220-30. doi: 10.1038/sj.cgt.7700290.
7
Peritoneal cancer treatment with CYP2B1 transfected, microencapsulated cells and ifosfamide.用CYP2B1转染的微囊化细胞和异环磷酰胺治疗腹膜癌。
Cancer Gene Ther. 2006 Jan 1;13(1):65-73. doi: 10.1038/sj.cgt.7700849.
8
Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.用胞嘧啶脱氨酶监测基因治疗:使用氚标记的5-氟胞嘧啶的体外研究。
J Nucl Med. 1996 Jan;37(1):87-94.
9
Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach.利用转录靶向方法实现白色念珠菌胞嘧啶脱氨酶基因的乳腺癌特异性表达。
Cancer Gene Ther. 2000 Jun;7(6):845-52. doi: 10.1038/sj.cgt.7700191.
10
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.使用腺病毒介导的胞嘧啶脱氨酶和尿嘧啶磷酸核糖转移酶融合基因转移进行结肠癌的体内基因治疗。
Gene Ther. 2001 Oct;8(20):1547-54. doi: 10.1038/sj.gt.3301557.

引用本文的文献

1
Phase I/II clinical trial of encapsulated, cytochrome P450 expressing cells as local activators of cyclophosphamide to treat spontaneous canine tumours.作为环磷酰胺局部激活剂治疗自发性犬类肿瘤的细胞色素P450表达封装细胞的I/II期临床试验。
PLoS One. 2014 Jul 16;9(7):e102061. doi: 10.1371/journal.pone.0102061. eCollection 2014.
2
Mouse mammary tumor virus promoter-containing retroviral promoter conversion vectors for gene-directed enzyme prodrug therapy are functional in vitro and in vivo.用于基因导向酶前药疗法的含小鼠乳腺肿瘤病毒启动子的逆转录病毒启动子转换载体在体内外均具有功能。
J Biomed Biotechnol. 2008;2008:683505. doi: 10.1155/2008/683505.
3
Gene therapy for carcinoma of the breast.
乳腺癌的基因治疗。
Cancer Gene Ther. 2006 Jul;13(7):633-47. doi: 10.1038/sj.cgt.7700929. Epub 2006 Jan 6.
4
Introduction to the background, principles, and state of the art in suicide gene therapy.自杀基因治疗的背景、原理及前沿进展介绍。
Mol Biotechnol. 2005 May;30(1):71-88. doi: 10.1385/MB:30:1:071.
5
Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy).用于基因导向酶-前药疗法(自杀基因疗法)的前体药物。
J Biomed Biotechnol. 2003;2003(1):48-70. doi: 10.1155/S1110724303209098.
6
A clinical protocol for treatment of canine mammary tumors using encapsulated, cytochrome P450 synthesizing cells activating cyclophosphamide: a phase I/II study.一项使用包封的、合成细胞色素P450激活环磷酰胺治疗犬乳腺肿瘤的临床方案:一项I/II期研究。
J Mol Med (Berl). 2002 Sep;80(9):610-4. doi: 10.1007/s00109-002-0356-0. Epub 2002 Jun 28.